All PlansCoverageMedium impact
Newsletter Vol. 2, No. 45
New Jersey Medicaid·NJ · Pulmonology, Pediatrics, Family Medicine +1 more·Pharmacy
We identified it
Jun 20, 2026
Summary
This policy update addresses processing pharmaceutical claims specifically for the Cystic Fibrosis Drug Program. The policy provides guidance on billing procedures and requirements for CF-related medications through this specialized program.
Action Required
Review Newsletter Vol. 2, No. 45 for updated procedures on processing pharmaceutical claims for Cystic Fibrosis Drug Program. Billing team should access the full policy document at the provided URL to understand specific requirements for CF medication claims processing and ensure compliance with program guidelines.